News

Dechra Pharmaceuticals Limited (Dechra) today announces the appointment of a new North American President

Laura Olsen will join Dechra as the new President of North America, effective September 9, bringing a wealth of experience in animal and human health, having previously worked at Zoetis, Pfizer, and Novartis.

Dechra Pharmaceuticals Limited (Dechra) announces the upcoming acquisition of Invetx

In line with its long-term strategy to be an innovation leader in health, Invetx specializes in developing protein-based therapeutics for companion animals' chronic conditions, focusing on monoclonal antibodies (mAbs).

Dechra Pharmaceuticals Limited today announces the appointment of Jesper Nordengaard as its CEO and retirement of Ian Page effective June 10, 2024

Jesper Nordengaard will join Dechra from Colgate-Palmolive where he is currently President, North America. Jesper previously was President and CEO of Hill’s Pet Nutrition, an iconic global pet food brand anchored in science and recommendation.

Dechra teams up with Fear Free to elevate veterinary care for pets

Dechra, a global leader in animal health, is excited to announce its strategic alliance with Fear Free®, an organization committed to reducing fear, anxiety, and stress in pets during veterinary visits. Through this collaboration, Dechra reinforces its commitment to seeing things from the veterinary perspective by supporting the Fear Free mission.

Dechra Veterinary Products extends its otitis range with the addition of DuOtic® (terbinafine and betamethasone acetate otic gel)

Dechra Veterinary Products is pleased to announce the expansion of its range of products to treat otitis externa with the addition of DuOtic® (terbinafine and betamethasone acetate otic gel).

Dechra Veterinary Products Partners with the Kentucky Horse Park to Provide Complimentary Parking for 2024

Dechra and the Kentucky Horse Park have teamed up to offer free parking for those touring the Park and many events in 2024.

Dechra Announces New Dechra Academy Course In Partnership with Not One More Vet, Inc.

Dechra Veterinary Products is pleased to announce the launch of their latest Dechra Academy course, Flavors of Fatigue, in partnership with Not One More Vet, Inc.

Dechra to Sponsor Several Upcoming Technician Focused Educational Opportunities

Dechra is excited to announce our support of numerous educational opportunities for veterinary technicians over the next few months. Across both companion animal and equine categories, we are sponsoring both in-person events and digital opportunities for veterinary technicians to add to their skills and knowledge.

Dechra Announces Sponsorship with Not One More Vet (NOMV)

Dechra is proud to announce our recent sponsorship of Not One More Vet (NOMV) to spread awareness and provide supportive programs for mental wellbeing in the veterinary industry.

Dechra Introduces Zenalpha^® (medetomidine and vatinoxan hydrochlorides injection) as Canine Sedative that Helps Minimize Cardiovascular Side Effects

Zenalpha is an innovative, new alpha-2 combination drug that minimizes the stress surrounding sedation in dogs while maximizing procedural efficiency.